K Number
K221448
Device Name
ARIA Radiation Therapy Management (v15.8), Eclipse Treatment Planning System (v15.8)
Date Cleared
2022-06-15

(28 days)

Product Code
Regulation Number
892.5050
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The ARIA Radiation Therapy Management product is a treatment application. It enables the authorized user to enter, access, modify, store and archive treatment plan and image data from diagnostic studies, treatment planning, simulation, plan verification and treatment. ARIA Radiation Therapy Management also stores the treatment histories including dose delivered to defined sites and provides tools to verify performed treatments. The Eclipse Treatment Planning System (Eclipse TPS) is used to plan radiotherapy treatments with malignant or benign diseases. Eclipse TPS is used to plan external beam irradiation with photon, electron and proton beams, as well as for internal irradiation (brachytherapy) treatments. In addition, the Eclipse Proton Eye algorithm is specifically indicated for planning proton treatment of neoplasms of the eye.
Device Description
The ARIA Radiation Therapy Management product is a treatment plan and image management application. It enables the authorized user to enter, access, modify, store and archive treatment plan and image data from diagnostic studies, treatment planning, simulation, plan verification and treatment. ARIA Radiation Therapy Management also stores the treatment histories including dose delivered to defined sites, and provides tools to verify performed treatments. ARIA Radiation Therapy Management supports the integration of all data and images in one central database including archiving and restoration. The different ARIA Radiation Therapy Management features support the visualization, processing, manipulation and management of all data and images stored in the system. Images can also be imported through the network using DICOM, the available image import filters or by means of film digitizers. The Varian Eclipse™ Treatment Planning System (Eclipse TPS) provides software tools for planning the treatment of malignant or benign diseases with radiation. Eclipse TPS is a computer-based software device used by trained medical professionals to design and simulate radiation therapy treatments. Eclipse TPS is capable of planning treatments for external beam irradiation with photon, electron, and proton beams, as well as for internal irradiation (brachytherapy) treatments.
More Information

No reference devices were used in this submission.

No
The summary describes software for managing radiation therapy data and planning treatments. It mentions image processing and various data management functions but does not include any terms or descriptions indicative of AI or ML technology being used for tasks like image analysis, treatment optimization, or prediction. The performance studies focus on software verification and validation, not AI/ML model performance.

No

These devices are treatment management and planning systems for radiotherapy, not devices that directly deliver therapy.

No

The devices described (ARIA Radiation Therapy Management and Eclipse Treatment Planning System) are explicitly stated to be for "treatment application" and "planning radiotherapy treatments," not for diagnosing diseases. While they handle data from "diagnostic studies," they themselves are not performing the diagnostic function.

No

The device description explicitly states it is a "computer-based software device," but the overall context of radiation therapy management and treatment planning strongly implies it is part of a larger system that includes hardware (e.g., linear accelerators, imaging equipment). The software manages data from diagnostic studies, treatment planning, simulation, verification, and treatment, which are processes that involve hardware. While the 510(k) summary focuses on the software components, it doesn't explicitly state that the device is only software and does not include or rely on specific hardware components for its core function as a medical device.

Based on the provided information, no, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body, such as blood, urine, or tissue, to provide information for diagnosis, monitoring, or screening.
  • Device Function: The ARIA Radiation Therapy Management and Eclipse Treatment Planning System are used for planning and managing radiation therapy treatments. They work with medical images and treatment data, not with biological specimens taken from the body.
  • Intended Use: The intended use clearly states that the devices are for "planning radiotherapy treatments" and "managing treatment plan and image data." There is no mention of analyzing biological samples.
  • Device Description: The description focuses on software tools for image processing, data management, and treatment planning. It does not describe any components or functions related to analyzing biological specimens.

Therefore, the function and intended use of these devices fall outside the scope of In Vitro Diagnostics. They are considered medical devices used in the context of radiation therapy treatment.

N/A

Intended Use / Indications for Use

The ARIA Radiation Therapy Management product is a treatment application. It enables the authorized user to enter, access, modify, store and archive treatment plan and image data from diagnostic studies, treatment planning, simulation, plan verification and treatment. ARIA Radiation Therapy Management also stores the treatment histories including dose delivered to defined sites and provides tools to verify performed treatments.

The Eclipse Treatment Planning System (Eclipse TPS) is used to plan radiotherapy treatments with malignant or benign diseases. Eclipse TPS is used to plan external beam irradiation with photon, electron and proton beams, as well as for internal irradiation (brachytherapy) treatments. In addition, the Eclipse Proton Eye algorithm is specifically indicated for planning proton treatment of neoplasms of the eye.

Product codes (comma separated list FDA assigned to the subject device)

IYE, MUJ

Device Description

The ARIA Radiation Therapy Management product is a treatment plan and image management application. It enables the authorized user to enter, access, modify, store and archive treatment plan and image data from diagnostic studies, treatment planning, simulation, plan verification and treatment. ARIA Radiation Therapy Management also stores the treatment histories including dose delivered to defined sites, and provides tools to verify performed treatments. ARIA Radiation Therapy Management supports the integration of all data and images in one central database including archiving and restoration. The different ARIA Radiation Therapy Management features support the visualization, processing, manipulation and management of all data and images stored in the system. Images can also be imported through the network using DICOM, the available image import filters or by means of film digitizers.

The Varian Eclipse™ Treatment Planning System (Eclipse TPS) provides software tools for planning the treatment of malignant or benign diseases with radiation. Eclipse TPS is a computer-based software device used by trained medical professionals to design and simulate radiation therapy treatments. Eclipse TPS is capable of planning treatments for external beam irradiation with photon, electron, and proton beams, as well as for internal irradiation (brachytherapy) treatments.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

trained medical professionals

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Software Verification and Validation Testing: ARIA Radiation Therapy Management and Eclipse Treatment Planning System were verified and validated according to the FDA Quality System Regulation (21 CFR §820) and other FDA recognized consensus standards. Test results demonstrate that the device conforms to design specifications and meets of the intended users, including assuring risk mitigations were implemented and functioned properly. Software verification testing were completed and documented provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices."

No data from animal studies or clinical tests have been included in this pre-market submission.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.

ARIA Radiation Therapy Management, version 15.5 (K173838), Eclipse Treatment Planning System, version 15.6 (K181145)

Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.

No reference devices were used in this submission.

Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).

Not Found

§ 892.5050 Medical charged-particle radiation therapy system.

(a)
Identification. A medical charged-particle radiation therapy system is a device that produces by acceleration high energy charged particles (e.g., electrons and protons) intended for use in radiation therapy. This generic type of device may include signal analysis and display equipment, patient and equipment supports, treatment planning computer programs, component parts, and accessories.(b)
Classification. Class II. When intended for use as a quality control system, the film dosimetry system (film scanning system) included as an accessory to the device described in paragraph (a) of this section, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.

0

Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Varian Medical Systems, Inc. % Mr. Peter J. Coronado Sr. Director, Regulatory Affairs 3100 Hansen Way PALO ALTO CA 94304

Re: K221448

Trade/Device Name: ARIA Radiation Therapy Management (v15.8), Eclipse Treatment Planning System (v15.8) Regulation Number: 21 CFR 892.5050 Regulation Name: Medical charged-particle radiation therapy system Regulatory Class: Class II Product Code: IYE, MUJ Dated: May 17, 2022 Received: May 18, 2022

Dear Mr. Coronado:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's

1

requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely,

for

Julie Sullivan, Ph.D. Assistant Director Radiation Therapy Team DHT 8C: Division of Radiological Imaging and Radiation Therapy Devices OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K221448

Device Name ARIA Radiation Therapy Management (v15.8)

Eclipse Treatment Planning System (v15.8)

Indications for Use (Describe)

The ARIA Radiation Therapy Management product is a treatment application. It enables the authorized user to enter, access, modify, store and archive treatment plan and image data from diagnostic studies, treatment planning, simulation, plan verification and treatment. ARIA Radiation Therapy Management also stores the treatment histories including dose delivered to defined sites and provides tools to verify performed treatments.

The Eclipse Treatment Planning System (Eclipse TPS) is used to plan radiotherapy treatments with malignant or benign diseases. Eclipse TPS is used to plan external beam irradiation with photon, electron and proton beams, as well as for internal irradiation (brachytherapy) treatments. In addition, the Eclipse Proton Eye algorithm is specifically indicated for planning proton treatment of neoplasms of the eye.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

| Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Image /page/3/Picture/0 description: The image contains three blue circles arranged horizontally. The circles are evenly spaced and appear to be of the same size. The background is plain white, which makes the circles stand out.

Image /page/3/Picture/1 description: The image shows the word "varian" in bold, black font. Below the word "varian" is the phrase "A Siemens Healthineers Company" in a smaller, less bold font. The text is aligned to the left and the background is white.

Varian Medical Systems

3100 Hansen Way Palo Alto, CA 94304

650.493.4000 800.544.4636

varian.com

510(k) Summary K221448

l. SUBMITTER

| Name and Address: | Varian Medical Systems, Inc.
3100 Hansen Way
Palo Alto, CA 94304 |
|-------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Contact Person: | Peter J. Coronado
Sr. Director, Regulatory Affairs
+1 (650) 424-6320 (phone) +1 (650) 646-9200 (fax)
submissions.support@varian.com |
| Date Prepared: | 17 May 2022 |

II. DEVICES

This is a bundled 510(k) for two devices: ARIA Radiation Therapy Management and Eclipse Treatment Planning System. The devices are submitted together to ensure that the shared scientific and regulatory considerations they raise are addressed within one review.

| Trade name: | ARIA Radiation Therapy Management, version
15.8 | Eclipse Treatment Planning System, version 15.8 |
|-------------------------|---------------------------------------------------------------------------|---------------------------------------------------------------------------|
| Common name: | ARIA Radiation Therapy Management | Treatment planning system, Eclipse |
| Classification
name: | Medical charged-particle radiation therapy
system
(21 CFR 892.5050) | Medical charged-particle radiation therapy
system
(21 CFR 892.5050) |
| Regulatory class: | Class II | Class II |
| Product code: | IYE | MUJ |

III. PREDICATE DEVICES

ARIA Radiation Therapy ManagementEclipse Treatment Planning System
Predicate device:ARIA Radiation Therapy Management, version
15.5 (K173838)Eclipse Treatment Planning System, version 15.6
(K181145)

No reference devices were used in this submission.

4

Image /page/4/Picture/0 description: The image shows the logo for Varian, a Siemens Healthineers Company. The word "varian" is written in a bold, sans-serif font. Below the word "varian" is the text "A Siemens Healthineers Company".

ARIA Radiation Therapy ManagementEclipse Treatment Planning System
Device
Description:The ARIA Radiation Therapy Management
product is a treatment plan and image
management application. It enables the
authorized user to enter, access, modify, store
and archive treatment plan and image data
from diagnostic studies, treatment planning,
simulation, plan verification and treatment.
ARIA Radiation Therapy Management also
stores the treatment histories including dose
delivered to defined sites, and provides tools to
verify performed treatments. ARIA Radiation
Therapy Management supports the integration
of all data and images in one central database
including archiving and restoration. The
different ARIA Radiation Therapy Management
features support the visualization, processing,
manipulation and management of all data and
images stored in the system. Images can also be
imported through the network using DICOM,
the available image import filters or by means
of film digitizers.The Varian Eclipse™ Treatment Planning System
(Eclipse TPS) provides software tools for planning
the treatment of malignant or benign diseases
with radiation. Eclipse TPS is a computer-based
software device used by trained medical
professionals to design and simulate radiation
therapy treatments. Eclipse TPS is capable of
planning treatments for external beam
irradiation with photon, electron, and proton
beams, as well as for internal irradiation
(brachytherapy) treatments.

IV. DEVICE DESCRIPTIONS

v. INTENDED USE AND INDICATIONS FOR USE

ARIA Radiation Therapy ManagementEclipse Treatment Planning System
Indications for
Use/Intended Use:The ARIA Radiation Therapy Management
product is a treatment plan and image
management application. It enables the
authorized user to enter, access, modify, store
and archive treatment plan and image data from
diagnostic studies, treatment planning,
simulation, plan verification and treatment.
ARIA Radiation Therapy Management also
stores the treatment histories including dose
delivered to defined sites and provides tools to
verify performed treatments.
(Same as predicate)The Eclipse Treatment Planning System (Eclipse
TPS) is used to plan radiotherapy treatments for
patients with malignant or benign diseases.
Eclipse TPS is used to plan external beam
irradiation with photon, electron and proton
beams, as well as for internal irradiation
(brachytherapy) treatments. In addition, the
Eclipse Proton Eye algorithm is specifically
indicated for planning proton treatment of
neoplasms of the eye.
(Same as predicate)

5

Image /page/5/Picture/0 description: The image shows the logo for Varian, a Siemens Healthineers Company. The word "varian" is written in a bold, sans-serif font. Below the word "varian" is the text "A Siemens Healthineers Company" in a smaller, sans-serif font. The logo is black and white.

VI. COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH THE PREDICATE DEVICE

Significant Differences

ARIA Radiation Therapy Management and Eclipse Treatment Planning System have the same technological characteristics as their predicate devices. All features are the same except for the following significant changes:

  • Implementation of multi-institution support with cloud hosted Eclipse TPS and ARIA RTM.
  • Changes in user workflow in support of multi-institution capability
  • The prevention of couch position edits after treatment approval and the prevention of inconsistent couch value editing (ARIA RTM only)

Both the new devices and the predicate devices provide tools for qualified medical professionals to do initial planning, review and approve candidate plans, and monitor ongoing treatments for patients to be treated with radiation therapy. There are no substantial changes in the principle of operation of the software or in the core algorithms.

VII. PERFORMANCE DATA

The following performance data were provided in support of the substantial equivalence determination.

Software Verification and Validation Testing

ARIA Radiation Therapy Management and Eclipse Treatment Planning System were verified and validated according to the FDA Quality System Regulation (21 CFR §820) and other FDA recognized consensus standards listed below. Test results demonstrate that the device conforms to design specifications and meets of the intended users, including assuring risk mitigations were implemented and functioned properly. Software verification testing were completed and documented provided as recommended by FDA's Guidance for Industry and FDA Staff, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices."

The level of concern for both devices is major because a failure or latent flaw in the software could directly result in serious injury or death to the patient or the operator.

Standards Conformance

The devices conform with the following standards:

  • IEC 62304:2006+A1:2015 Medical device software – Software lifecycle processes
  • . IEC 62366-1:2015 Medical devices – Part 1: Application of usability engineering to medical devices
  • IEC 62083:2009 Medical electrical equipments for the safety of radiotherapy treatment planning systems (Eclipse Treatment Planning Only)
  • IEC 82304-1:2016 Health software – Part 1: General requirements for product safety
  • . IEC 62274:2005 Medical electrical equipment – Safety of radiotherapy record-and-verify systems (ARIA Radiation Therapy Management only)
  • IEC 61217:2011 Radiotherapy equipment – Coordinates, movements, and scales

Additional general (non-device-specific) standards applied include:

  • EN ISO 13485:2016 Medical devices – Quality management systems – Requirements for regulatory purposes
  • EN ISO 14971:2019 Medical devices – Application of risk management to medical devices
  • ISO 15223-1:2016 Medical devices – Symbols to be used with medical device labels, labeling, and information to be supplied
  • BS EN 1041:2008+A1:2013 – Information Supplied by the manufacturer of medical devices

VIII. CLINICAL TESTING

6

Image /page/6/Picture/0 description: The image shows the logo for Varian, a Siemens Healthineers Company. The word "Varian" is written in a bold, sans-serif font. Below the word "Varian" is the text "A Siemens Healthineers Company" in a smaller, sans-serif font. The logo is black and white.

No data from animal studies or clinical tests have been included in this pre-market submission.

IX. CONCLUSIONS

ARIA Radiation Therapy Management 15.8 and Eclipse Treatment Planning System 15.8 are substantially equivalent to ARIA Radiation Therapy Management 15.5 and Eclipse Treatment Planning System 15.6 respectively. The intended use and indications for use are the same. The major technological characteristics are substantially equivalent to the predicate devices, and the differences do not raise new questions of safety and effectiveness. The results of verification and validation as well as conformance to relevant safety standards demonstrate that ARIA Radiation Therapy Management 15.8 and Eclipse Treatment Planning System 15.8 meet safety and are substantially equivalent to their predicate devices.